A pharmacokinetic model describing the removal of circulating radiolabeled antibody by extracorporeal immunoadsorption
- 1 August 1991
- journal article
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 19 (4) , 385-403
- https://doi.org/10.1007/bf01061663
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Computer Simulation of Ciprofloxacin Pharmacokinetics in Patients on CAPDThe International Journal of Artificial Organs, 1990
- A new approach to pharmacokinetic parameters: Estimation of cefuroxime during haemodialysisBiopharmaceutics & Drug Disposition, 1990
- Primary lung cancer: biodistribution and dosimetry of two In-111-labeled monoclonal antibodies.Radiology, 1989
- Co-Trimoxazole (Sulphamethoxazole plus Trimethoprim) Peritoneal Barrier Transfer PharmacokineticsClinical Pharmacokinetics, 1989
- A preliminary pharmacokinetic study of 111In-labeled 260F9 anti-(breast cancer) antibody in patientsCancer Immunology, Immunotherapy, 1989
- PHARMACOKINETICS OF IN-111 LABELED OC-125 ANTIBODY IN CANCER-PATIENTS COMPARED WITH THE 19-9 ANTIBODY1987
- PHARMACOKINETICS OF THE MONOCLONAL-ANTIBODY B72.3 AND ITS FRAGMENTS LABELED WITH EITHER I-125 OR IN-1111987
- Basic principles and applications of monoclonal antibodies in the management of carcinomas: the Richard and Hinda Rosenthal Foundation award lecture.1986
- Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy.1985
- PHARMACOKINETICS OF AN INDIUM-111-LABELED MONOCLONAL-ANTIBODY IN CANCER-PATIENTS1985